lobbying_activities: 796104

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
796104	45b0dc17-9bda-4fad-a06a-2036b6e82f28	Q2	AMYLIN PHARMACEUTICALS	308536	AMYLIN PHARMACEUTICALS	2009	second_quarter	PHA	Payment disclsoure regulations in the Physician Payments Sunshine Act of 2009 Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Regulatory provisions in the Food and Drug Administration Globalization Act of 2009 (H.R. 759) Drug Importation/Drug Safety	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		320000	0	0	2009-07-17T10:50:00-04:00